European Pharmaceutical Review

OCTOBER 25, 2023

Three key medicine regulatory bodies from the UK, US and Canada have collaborated to publish five guiding principles for machine learning-enabled medical devices MLMDs. These principles will support PCCP development across the UK, US and Canada. MHRA announced that it will publish its guidance in 2024.

Documentation 90

Documentation FDA 90

Pharmaceutical Technology

APRIL 10, 2023

The company strengthens the translational research collaboration between the US and Ireland. Aviceda co-founder and chief technology officer Dr Michael Tolentino said: “This commercial investment is a testament to collaboration across the island of Ireland and the US. “It

Immunization 103

Immunization 103

PQA

APRIL 19, 2024

Collaboration is one of PQA's greatest attributes, and our measure development process embodies how our diverse member organizations reach consensus on evaluating medication use quality. Read more about PQA's ongoing work to improve OAM use quality. Make plans to join us! Register to join us today!

Communication 52

Communication 52

European Pharmaceutical Review

MARCH 19, 2024

Under a new deal, Novartis has agreed to acquire US-based biopharma company IFM Therapeutics, for a total of up to $835 million. Further details of Novartis’ current acquisition The current acquisition follows a four-year preclinical collaboration between Novartis and IFM, according to Siegel.

Immunization 96

Immunization 96

European Pharmaceutical Review

JANUARY 5, 2024

The therapeutic is designed using the artificial intelligence (AI)-platform from Insilico Medicine, the biotech company that is also part of this collaboration. The post Collaboration to develop novel AI-designed oncology therapy appeared first on European Pharmaceutical Review. This is is most common breast cancer subtype.

102

102

Pharmaceutical Technology

OCTOBER 25, 2022

BioMed X Institute founder and managing director Christian Tidona said: “Our new collaboration with Sanofi allows us to further extend our data science and AI expertise in Heidelberg, where we have developed an ideal incubation environment for biomedical innovation at the interface between academia and industry.”.

Immunization 98

Immunization 98

PQA

FEBRUARY 23, 2024

Join us next Thursday, February 29, from 1:00-2:00 p.m. Program pharmacists work closely with the patient’s psychiatrist in a collaborative care model. See our blog for more details on this initiative, and register to join us for the webinar. Make plans to join us! The registration link is in the Member Resources Library.

Hospitals 52

Hospitals 52

Pharmaceutical Technology

AUGUST 1, 2022

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. The post GreenLight and US NIH partner to develop Covid-19 vaccine for variants appeared first on Pharmaceutical Technology.

Vaccines 98

Vaccines Immunization 98

Outsourcing Pharma

AUGUST 24, 2021

The regional US healthcare system will collaborate with the health intelligence specialist to advance precision medicine focused on oncological care.

105

105

Pharmaceutical Technology

MAY 4, 2023

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. In April 2023, Forge Biologics received a qualified person (QP) declaration for the manufacture of AAV gene therapies at its facility in Columbus, Ohio, US.

102

102

Pharmaceutical Technology

MAY 8, 2023

This deal also includes option rights for a strategic collaboration. The collaboration will help in further development of BB-1701 across the world and advance the ADC towards late stage of development. Currently, BB-1701 is being evaluated in Phase I/II trials in China and the US.

98

98

pharmaphorum

FEBRUARY 18, 2021

GlaxoSmithKline is expanding a coronavirus antibody collaboration with US biotech Vir, to include potential therapies for flu and other respiratory viruses. The expanded collaboration provides GSK with exclusive rights to collaborate with Vir on the development of potential monoclonal antibodies (mAbs) to prevent or treat influenza.

103

103

Hospital Pharmacy Europe

SEPTEMBER 11, 2023

Greater ethnic diversity in pioneering breast cancer clinical trials is the primary objective of a recent collaborative pilot project between Barts Health NHS Trust, The Christie NHS Foundation Trust, Roche Products Ltd and Macmillan Cancer Support. A further possible reason is the lack of engagement with ethnic communities.

Communication 105

Communication Hospitals 105

Pharmaceutical Technology

MARCH 16, 2023

Global biopharmaceutical firm UCB has entered an early drug discovery collaboration with Aitia. The collaboration is aimed at discovering and validating new drug targets and drug candidates that are linked to clinical endpoints causally in Huntington’s disease, a debilitating genetic disorder.

93

93

Pharmaceutical Technology

JUNE 6, 2023

Lotus Pharmaceuticals, NRx Pharmaceuticals and Alvogen have entered a global collaboration deal to develop and commercialise NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD). Lotus will purchase global rights for NRX-101 and handle the commercialisation activities of the product in markets outside the US.

Labelling 52

Labelling FDA 52

Pharmafile

AUGUST 29, 2023

ImmunoGen has announced that it has entered into an exclusive collaboration with Takeda Pharmaceutical Company for the development and commercialisation of Elahere (mirvetuximab soravtansine-gynx) in Japan.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

DECEMBER 19, 2023

We are excited to collaborate with Otsuka given their proven results in bringing rare disease medicines to patients in Europe,” said Brett Monia, Ionis chief executive officer. He added that agreement is aligned with Ionis’ strategy to “initially focus commercialisation efforts on the US market.” attacks per month to 0.06

Labelling 92

Labelling 92

PharmaShots

MAY 12, 2023

Shots: SERB retains an exclusive US right to the ticagrelor reversal agent bentracimab. SFJ will lead an ongoing clinical trial of bentracimab & will submit the BLA to the US FDA, expected to file in 2023 in collaboration with SERB The collaboration will use SERB’ to advance bentracimab.

FDA 53

FDA 53

European Pharmaceutical Review

JULY 13, 2022

Afrigen Biologics and the US National Institute of Allergy and Infectious Diseases (NIAID) have agreed to share technical expertise related to the development of next-generation messenger RNA (mRNA) vaccines and therapeutics. . Site visits are planned, with Afrigen expected to visit the VRC in Maryland, US, later this year. .

Vaccines 71

Vaccines 71

European Pharmaceutical Review

APRIL 8, 2024

The first BCMA-targeted CAR-T cell therapy for second-line treatment of multiple myeloma has been approved by the US Food and Drug Administration (FDA). When the cilta-cel CAR protein binds to BCMA-expressing cells, the CAR promotes T-cell activation, expansion, and elimination of target cells, Legend Biotech explained.

FDA 95

FDA Labelling 95

Pharmaceutical Technology

SEPTEMBER 13, 2022

Microsoft is offering AI technology, foundational science models and capabilities through collaboration. . To expedite Novo Nordisk's research and development (R&D), Microsoft is also collaborating with the former’s data researchers and domain specialists from initial research and development regions.

139

139

Pharmaceutical Technology

MAY 23, 2023

Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade vaccine adjuvant QS-21. Croda Pharma and BSI will share their knowledge to bring QS-21 to market from quillaja Saponaria plant cell culture, which is made from the soap bark tree.

Vaccines 96

Vaccines 96

PQA

JANUARY 26, 2024

Scientific innovation and medical advancements allow us to live longer, healthier lives, but the ethical and financial challenges caused by access and affordability issues necessitate crucial conversations about how health care is delivered. Make plans to join us! The registration link is in the Member Resources Library.

Specialty Pharmacies 59

Specialty Pharmacies Patient Care 59

European Pharmaceutical Review

JANUARY 23, 2023

The US Food and Drug Administration (FDA) has granted fast track designation (FTD) for Evaxion Biotech’s personalised cancer immunotherapy. This process uses Evaxion’s proprietary AI platform. This trial is being carried out in collaboration with Merck across the US, Europe, and Australia. Moderna, Inc.

Immunization 121

Immunization Vaccines FDA 121

European Pharmaceutical Review

MARCH 7, 2023

Emerging Sciences and Technology Chris Brabrandt, Head of Ideation & Scouting (Open Innovation) in the digital lab, at Boehringer Ingelheim, Germany Giuseppe Cognetti, Head, Future of Healthcare and Excellence at Takeda, Boston, US Thomas Ehmer, Innovation Incubator Lead at Merck KGaA, Darmstadt, Germany.

Pharmaceutical Companies 65

Pharmaceutical Companies Pharmaceutical Companies 65

pharmaphorum

OCTOBER 7, 2022

Two additional novel AI-generated targets for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF) have been discovered using the Benevolent Platform and selected for AstraZeneca’s (AZ) drug discovery portfolio. BenevolentAI’s collaboration with AZ permits integration of the data collected into its biomedical Knowledge Graph.

102

102

PQA

FEBRUARY 9, 2024

Join us as we head back to Baltimore for the 2024 PQA Annual Meeting, May 14-16! Registration is open, so make your plans now to join us and other quality professionals at the premier event for medication use quality. Make plans to join us! Enhance the impact of your attendance by becoming a sponsor of the meeting.

59

59

PQA

MARCH 8, 2024

Ensuring the quality of medication use is critically important for rare disease patients, payers, clinicians, specialty pharmacies and everyone with a role in the care process. If you have questions or would like to be involved, email us at Communications@PQAalliance.org. The registration link is in the Member Resources Library.

Community Pharmacies 52

Community Pharmacies Specialty Pharmacies Independent Pharmacies Documentation 52

European Pharmaceutical Review

DECEMBER 14, 2022

have announced their collaboration to advance potential therapeutics of KCNT1 related epilepsies, based on Praxis’ PRAX-020 small molecule programme, enabling Praxis to be potentially eligible to around $100 million in development milestones and related payments. Two biopharmaceutical companies, UCB and Praxis Precision Medicines Inc.,

89

89

Pharmaceutical Technology

JUNE 20, 2023

Santhera Pharmaceuticals and Catalyst Pharmaceuticals have signed an exclusive licence and collaboration deal for Santhera’s vamorolone in the US, Canada and Mexico. In the US and Europe, the drug has received orphan drug status to treat Duchenne muscular dystrophy (DMD).

FDA 98

FDA 98

Pharmaceutical Technology

FEBRUARY 23, 2023

GenScript ProBio has announced a strategic collaboration with RVAC Medicines to manufacture GMP-grade plasmid DNA (pDNA) for the latter’s RVM-V001, an mRNA Covid-19 vaccine candidate. Under the agreement, GenScript ProBio will offer GMP plasmid manufacturing service for the RVM-V001 programme.

Vaccines 115

Vaccines Communication 115

PQA

MARCH 22, 2024

Have you made your plans to join us at the 2024 PQA Annual Meeting, May 14-16, in Baltimore? Evaluating Community Pharmacy Quality The Community Pharmacy Enhanced Service Network (CPESN) special purpose network, CPESN Health Equity, is currently using the Choose My Pharmacy system across their entire membership. Make plans to join us!

Health and Personal Care Stores 40

Health and Personal Care Stores Community Pharmacies Medication Delivery Immunization 40

European Pharmaceutical Review

DECEMBER 21, 2022

In the earlier statement, the regulatory agency noted that clinical research “…is a critical step in the generation of good quality evidence needed to better understand the potential health benefits and harms associated with the therapeutic use of psilocybin.” Expediated pathways available for psychedelics. Adaptive pathways.

Compounding 107

Compounding Controlled Substances FDA Patient Care 107

ISPE

NOVEMBER 23, 2022

The symposium was titled “Thriving at 50 and Striving Forward” and was aimed at promoting and highlighting PIC/S’ contributions to international collaboration and co-operation. The PIC/S Deputy Chairperson, Susan Laska, US FDA, outlined the evolution of pharma industry and PIC/S, including background information on the operations of PIC/S.

Documentation 98

Documentation FDA Communication 98

pharmaphorum

MAY 19, 2022

The inaugural Targeted Radiopharmaceuticals Summit US will bring together a worldwide community of specialists to address long-standing challenges in radiopharmaceutical development at all stages, from bench to bedside. The post Targeted Radiopharmaceuticals Summit US (TRP US) appeared first on.

104

104

PQA

JANUARY 12, 2024

is collaborating with Soda Health to reduce food insecurity and promote healthy living. Make plans to join us! PQA’s collaborative approach makes its meetings a preferred destination for quality improvement professionals. Reducing Food Insecurity and Promoting Health Living Hy-Vee Inc.

Specialty Pharmacies 64

Specialty Pharmacies Vaccines 64

European Pharmaceutical Review

NOVEMBER 10, 2022

Minoryx and Neuraxpharm will collaborate to finish the ongoing European regulatory process to obtain approval for leriglitazone for the treatment of adult male patients with X-ALD. Another important part of the work will consist of closely collaborating with patient advocacy groups and associations.

FDA 96

FDA 96